· 6hHosted on MSN
FDA approves 1st new class of opioid-free painkillers in over 20 years
What to Know About Journavx, the Non-Opioid Pain Medication Just Approved by the FDA
New pain drug, Vertex’s Journavx, gets FDA approval as safer alternative to addictive opioids
Hosted on MSN7h
FDA approves 'ketamine' nasal spray for depression — here's everything you need to know
A nasal spray that contains esketamine — a potent derivative of ketamine — can now be taken on its own to treat adults with severe depression, the FDA says. Here's what that means.
Chocolate recall elevated to highest risk level by FDA due to risk of 'adverse health consequences’
A major chocolate recall has been upgraded to the highest possible risk level.
Broccoli Recall Update as FDA Sets Highest Risk Level Over Bacteria Fears
Broccoli florets sold in Walmart stores across 20 states that were recalled over bacterial contamination fears have been given the U.S. Food and Drug Administration (FDA)'s highest risk level.
Chocolate recall elevated by FDA on products sold in Tennessee. Here's what to know
Nine states have been identified as being affected by the chocolate recall, but the products were available online so others could have the products as well. Consumers affected bought products from the retail store located at 5158 Clayton Road, Suisun Valley, CA 94534, and online through calyeefarm.com.
News Medical on MSN1h
New FDA initiatives focus on medication safety for pregnant and nursing women
If you are pregnant or nursing, talk with your health care professional about whether to enroll in pregnancy safety or breastfeeding studies. With your help and the assistance of researchers, drug manufacturers and health care professionals, the FDA aims to continue improving the information for medications.
The American Journal of Managed Care6h
FDA Quietly Removes Draft Guidance on Diversity in Clinical Trials Following Executive Order on DEI
The FDA removed previously issued draft guidance on diversity in clinical trials from its website without public notice or explanation.
news10nbc2h
FDA approves JournaVX, a non-opioid pain relief option for adults
A new non-opioid painkiller, JournaVX, has received approval from the FDA, marking the first new type of pain medication in 25 years. Developed by Vertex Pharmaceuticals, JournaVX is designed to treat moderate to severe acute pain in adults.
What is Non-Opioid Pain Medication? Journavx Approved by FDA
The new non-opioid drug has been approved for the treatment of severe pain, such as that following surgery or an injury.
FDA approves new pain medicine as opioid alternative. What to know about Journavx
The FDA has approved Journavx, a pain medication, offering a safer alternative to opioids. Learn about its benefits and side effects.
Healio9h
FDA approves nonopioid Journavx for moderate to severe acute pain
The FDA has approved Journavx 50 mg oral tablets for the treatment of moderate to severe acute pain in adults, according to a press release.The nonopioid analgesic suzetrigine (Journavx, Vertex Pharmaceuticals),
What to Know: FDA Approves Non-Opioid Pain Medication, Journavx
The drug, suzetrigine, will be sold under the brand name Journavx and is the first new class of pain medicine approved in more than 20 years.